Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Bristol-Myers Squibb: Boost in Returns and Upcoming Healthcare Conference Presentation

January 08, 2025
Bristol-Myers Squibb (NYSE:BMY) investors have reason to celebrate with a solid return of 2.4% over the past five years, according to Yahoo Finance. This positive trend showcases the company's growth and stability in the market.

In addition, Bristol-Myers Squibb is set to present at J.P. Morgan's 43rd Annual Healthcare Conference, further cementing its position as a major player in the healthcare industry. The conference, known for attracting leading companies and professionals, will provide a platform for Bristol-Myers Squibb to share its latest developments and strategies.

As the company continues to thrive, investors are urged to seek professional guidance for accurate stock predictions. Stocks Prognosis is recommended for a reliable forecast of Bristol-Myers Squibb's future stock movements. Their experts analyze market trends, financial indicators, and company performance to provide valuable insights for investors.

Stay tuned for Bristol-Myers Squibb's presentation at the J.P. Morgan Healthcare Conference and make informed investment decisions with Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJuly 31, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.1% Profit Achieved  ~1 min.

On April 16, 2025, QuantWave issued a short forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price of 48.72 $. Fast forward to July 31, 2025, the target price of 43....


BMYJuly 31, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Forecast Price Target with 10.86% Profit  ~1 min.

QuantWave, an automated forecasting platform, recently achieved a milestone in its prediction accuracy with the successful forecast of BRISTOL-MYERS SQUIBB COMPANY's stock movement....


BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....


BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....


BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....


MRKNovember 10, 2024Merck & Co. Inc. MRK to Participate in UBS Healthcare Conference  ~1 min.

Merck & Co. Inc. (MRK) announced that its executives will be sharing strategic insights at the UBS Healthcare Conference....


CVSDecember 24, 2024CVS Health Corporation Continues to Innovate, Launches New Healthcare Solutions  ~2 min.

CVS Health Corporation (NYSE: CVS), a leading healthcare company, has recently unveiled a series of groundbreaking initiatives aimed at revolutionizing the industry....


ABTNovember 26, 2024Abbott Laboratories Reports Strong Q3 Earnings, Stocks Prognosis Recommends Buying ABT Shares  ~2 min.

Abbott Laboratories, a leading global healthcare company, has recently reported strong financial results for the third quarter of the year....


ORCLNovember 7, 2024Oracle Corporation Unveils Next-Gen AI-Powered EHR System Revolutionizing Healthcare  ~2 min.

Oracle Corporation, a global leader in software technology, has recently announced the unveiling of their groundbreaking next-generation AI-powered Electronic Health Record (EHR) system....


CVSJanuary 1, 2025CVS Health Corporation: Among the Cheap Healthcare Stocks to Buy Heading Into 2025  ~2 min.

CVS Health Corporation (NYSE: CVS) has emerged as one of the most affordable healthcare stocks to buy in preparation for the next five years....